Back | Next |
home / stock / sesn / sesn message board
Subject | By | Source | When |
---|---|---|---|
I like the trading action. Something Maybe brewing | govprs | investorshub | 10/28/2022 5:43:21 PM |
If they license or sell Vincineum rights SHs | mrplmer | investorshub | 10/23/2022 6:47:53 PM |
They're basically getting their RS through the merger | MD3 | investorshub | 10/14/2022 9:38:06 PM |
Vincineum held out of the merger. Still looking | mrplmer | investorshub | 10/13/2022 6:04:39 PM |
What's going to happen with $SESN shareholders after | OrizG | investorshub | 10/13/2022 5:36:31 PM |
Vincineum for Bladder Cancer is for sale NOW. | mrplmer | investorshub | 10/09/2022 11:13:16 AM |
It's very possible he wants to sell it. | Bill_ENG | investorshub | 10/09/2022 3:38:33 AM |
I think Cannell want to sell Vini for | mrplmer | investorshub | 10/06/2022 8:15:38 PM |
Tommy probably feels he can't dangle the Vici | MD3 | investorshub | 09/22/2022 12:46:52 AM |
Read about merger. Vincineum on back burner. | mrplmer | investorshub | 09/21/2022 8:42:54 PM |
What is the deal? Sorry I | OmahaInvestor | investorshub | 09/21/2022 7:07:33 PM |
Tommh is a real POS. This deal sucks. | mrplmer | investorshub | 09/21/2022 2:37:02 PM |
Sure looks that way | govprs | investorshub | 09/21/2022 1:38:02 PM |
Not the news folks wanted. Investors wanted an | MD3 | investorshub | 09/21/2022 1:29:17 PM |
Merger announced | govprs | investorshub | 09/21/2022 1:25:13 PM |
Sesen Bio $SESN... carrying a Zacks Rank #1 | joe_techi | investorshub | 08/30/2022 9:10:59 PM |
They are close IMO. Even the company | aquaspin | investorshub | 08/24/2022 2:41:46 AM |
Come on Tommy Let's make a deal! It'sa | mrplmer | investorshub | 08/22/2022 12:55:17 PM |
Then might as well hold on to my | govprs | investorshub | 08/02/2022 11:21:58 PM |
My guess is Cannell has a deal if | mrplmer | investorshub | 08/02/2022 9:13:22 PM |
News, Short Squeeze, Breakout and More Instantly...
Sesen Bio Inc. Company Name:
SESN Stock Symbol:
NASDAQ Market:
Declares Special Dividend in the Aggregate of $75 Million Approximately 88% Voted in Favor of the Merger at the Special Meeting Merger on Track to Close on March 7, 2023 Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today anno...
Sesen Bio Board Believes the Pending Merger with Carisma is the Most Value-Maximizing Option for Stockholders Reiterates Support from Several of Sesen Bio’s Largest Stockholders and Two Leading Independent Proxy Advisors Sesen Bio Board Unanimously Recommends All St...
Positive Recommendations Underscore that Carisma Merger Maximizes Value for Sesen Bio Stockholders Sesen Bio Board Unanimously Recommends All Stockholders to Follow ISS and Glass Lewis’s Recommendations to Vote “FOR” Value Maximizing Merger on WHITE ...